Ledger.Open graph →
SEC Form D · filed July 1, 2020

Compass Therapeutics, Inc

Offering
$70.0M
Sold
$60.5M
Exemption
Rule 506(b)
Industry
Other
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Philip J. Ferneau · Cambridge, MADirectorStephen P. Squinto · Cambridge, MADirectorVered P. Bisker-Leib · Cambridge, MAExecJulie Sunderland · Cambridge, MADirectorCarl L. Gordon · Cambridge, MADirectorThomas J. Schuetz · Cambridge, MAExec · DirectorMichael Lythcott · New York, NYDirectorToshiya Otani · PALO ALTO, CAExec · DirectorDerek Yoder · Sheridan, WYDirectorTaras Chumachenko · Moscow, 1ZExecAdrian Muhammad · Windermere, FLDirectorMelanie Mcdaniel · Sheridan, WYDirectorJohn R. Totaro · New York, NYDirectorAnna M. Palmer · New York, NYDirectorCharles M. Hazard, Jr · New York, NYExec · DirectorGary J. Crittenden · Salt Lake City, X1ExecJulia J. Vander Ploeg · Salt Lake City, UTDirectorAri Newman · Dover, DEDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗